about
Medical history, lifestyle, family history, and occupational risk factors for sporadic Burkitt lymphoma/leukemia: the Interlymph Non-Hodgkin Lymphoma Subtypes ProjectOccupational exposure to endocrine disruptors and lymphoma risk in a multi-centric European study.Aberrant Epstein-Barr virus antibody patterns and chronic lymphocytic leukemia in a Spanish multicentric case-control study.Non-Hodgkin Lymphoma, Body Mass Index, and Cytokine Polymorphisms: A Pooled Analysis from the InterLymph Consortium.Motivations for participating in a clinical trial on an avian influenza vaccineMenstrual and Reproductive Factors and Risk of Gastric and Colorectal Cancer in Spain.Menstrual and reproductive factors, and hormonal contraception use: associations with non-Hodgkin lymphoma in a pooled analysis of InterLymph case-control studies.Postmenopausal hormone therapy and non-Hodgkin lymphoma: a pooled analysis of InterLymph case-control studiesA Pooled Analysis of Reproductive Factors, Exogenous Hormone Use, and Risk of Multiple Myeloma among Women in the International Multiple Myeloma ConsortiumA pooled analysis of alcohol consumption and risk of multiple myeloma in the international multiple myeloma consortium.Vaccination strategies against hepatitis A in travelers older than 40 years: an economic evaluation.Night shift work and stomach cancer risk in the MCC-Spain study.Fruit and vegetable intake and vitamin C transporter gene (SLC23A2) polymorphisms in chronic lymphocytic leukaemia.Night shift work and chronic lymphocytic leukemia in the MCC-Spain case-control study.Hormonal contraception and postmenopausal hormone therapy in Spain: time trends and patterns of use.Seroreactivity against Merkel cell polyomavirus and other polyomaviruses in chronic lymphocytic leukaemia, the MCC-Spain study.Comment on: 'Second to fourth digit ratio (2D:4D), breast cancer risk factors, and breast cancer risk: a prospective cohort study'.Can the response to 23-valent pneumococcal vaccine in splenectomised patients be predicted?Reliability of 2D:4D measurements using a direct method suitable for clinical settingsCervical cancer vaccination indications, efficacy, and side effectsSensitivity of cervico-vaginal cytology in endometrial carcinoma: A systematic review and meta-analysisNew perspectives on screening and early detection of endometrial cancerDefining a mutational signature for endometrial cancer screening and early detection[Knowledge, clinical skills and interests of medical residents and interns (MIR) when first joining the hospital]
P50
Q34137897-D2AB0E69-ABCB-469B-B364-5780C24AC669Q35275008-C6622015-0915-4745-8ACC-2907F1C59B6DQ35599997-5D5DE9CD-F284-4C42-8924-A94AE0137B47Q35815614-59FDD9E3-76F8-4220-A5DA-7F449D0DC3F1Q35945862-F9DFF27C-2D45-448C-99E2-F100D4600C86Q36173064-85888C69-19CB-4C5C-B346-624747D010D9Q36182352-866D1234-506A-497A-85E4-7DBD9EF3822AQ36551642-CC1855DA-D107-4350-BDFD-9FEE983147A6Q36556093-075E5D16-969B-4020-9B0E-53AD8C6077BAQ37161198-EE56E0EB-43EA-4AB5-B319-D76D9CE8D45BQ37606522-97ACEF2F-E1BB-41D1-BE08-1EAE71D1BB34Q39676999-EB4FC195-F787-4258-AEC9-2CFDE46D9F7BQ40029874-C8F97FA9-1455-49E8-906E-0DDE904900B3Q40613608-06D1693F-80FF-4C06-82A1-0DDB067CCC54Q40782276-ECB50C10-C713-4A14-97A6-0A7895225A09Q41004055-95220CD2-BBBA-4AB6-A72A-065080BF17BBQ43232468-234338F4-4103-48F8-89DA-8EAF28036118Q43648723-2B00F9AA-73FC-48B5-97E0-B7A65E5E082CQ57129337-3579AC99-7A7A-468A-9C77-8173CC83E6B7Q81542013-7CA05565-7E4A-4ADA-973E-8FF33F5718B2Q90586260-E292480F-E858-4418-8B39-682D44548C9AQ92748518-4BEDEE74-3AD4-4204-A56F-845542C398AFQ93015842-E6FBC88A-024D-49EF-A538-D87577D64448Q94877794-F3BB4233-7924-4567-A426-380F14E5B8BA
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Laura Costas
@ast
Laura Costas
@en
Laura Costas
@es
Laura Costas
@nl
type
label
Laura Costas
@ast
Laura Costas
@en
Laura Costas
@es
Laura Costas
@nl
prefLabel
Laura Costas
@ast
Laura Costas
@en
Laura Costas
@es
Laura Costas
@nl
P106
P1153
30467570500
P21
P31
P496
0000-0003-2755-302X